ABSTRACT
A 49-year-old male with a body mass index (BMI) of 54 was electively admitted for a laparoscopic Roux en Y gastric bypass (RYGB). The patient completed a 6-month preoperative wellness (behavioral modification, nutrition, and fitness) program that resulted in a preoperative weight loss of 34 lbs. During that time the patient underwent clinical evaluations by cardiology, pulmonology, gastroenterology, and psychology services and was deemed safe to undergo the procedure. The patient’s comorbidities included hypertension, Type 2 diabetes, obstructive sleep apnea (OSA), low back and joint pain, and gastroesophageal reflux disease (GERD). Medications included atenolol, glyburide, hydrochlorothiazide, amlodipine, metformin, and nexium.
